Suppr超能文献

关于隐源性卒中的临床管理的当前观点。

Current perspectives on the clinical management of cryptogenic stroke.

机构信息

Department of Neurology, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, USA.

Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA.

出版信息

Expert Rev Neurother. 2023 Mar;23(3):213-226. doi: 10.1080/14737175.2023.2192403. Epub 2023 Mar 19.

Abstract

INTRODUCTION

Cryptogenic stroke is a heterogeneous entity defined as an ischemic stroke for which no probable cause is identified despite thorough diagnostic evaluation. Since about a quarter of all ischemic strokes are classified as cryptogenic, it is a commonly encountered problem for providers as secondary stroke prevention is guided by stroke etiology.

AREAS COVERED

In this review, the authors provide an overview of stroke subtype classification schemes and diagnostic evaluation in cryptogenic stroke. They then detail putative cryptogenic stroke mechanisms, their therapeutic implications, and ongoing research. This review synthesizes the available evidence on PubMed up to December 2022.

EXPERT OPINION

Cryptogenic stroke is an evolving concept that changes with ongoing research. Investigations are focused on improving our diagnostic capabilities and solidifying useful constructs within cryptogenic stroke that could become therapeutically targetable subgroups within an otherwise nonspecific entity. Advances in technology may help move specific proposed cryptogenic stroke mechanisms from undetermined to known source of ischemic stroke.

摘要

简介

隐源性卒中是一种异质性实体,定义为尽管经过彻底的诊断评估,但仍未确定可能的病因的缺血性卒中。由于约四分之一的缺血性卒中区分为隐源性,因此对于提供者来说,这是一个常见的问题,因为二级卒中预防取决于卒中病因。

涵盖领域

在这篇综述中,作者提供了卒中亚型分类方案和隐源性卒中诊断评估的概述。然后详细介绍了可能的隐源性卒中机制、其治疗意义以及正在进行的研究。这篇综述综合了截至 2022 年 12 月在 PubMed 上的可用证据。

专家意见

隐源性卒中是一个不断发展的概念,随着研究的不断深入而变化。研究的重点是提高我们的诊断能力,并在隐源性卒中中确定有用的结构,这些结构可能成为治疗靶点,将其从原本非特异性的实体中分离出来。技术的进步可能有助于将特定的隐源性卒中机制从不明原因的缺血性卒中来源转变为已知来源。

相似文献

1
Current perspectives on the clinical management of cryptogenic stroke.关于隐源性卒中的临床管理的当前观点。
Expert Rev Neurother. 2023 Mar;23(3):213-226. doi: 10.1080/14737175.2023.2192403. Epub 2023 Mar 19.
2
Cryptogenic Stroke: Diagnostic Workup and Management.隐源性卒中:诊断检查与管理
Curr Treat Options Cardiovasc Med. 2019 Dec 3;21(11):77. doi: 10.1007/s11936-019-0786-4.
3
The Evolving Concept of Cryptogenic Stroke.隐源性卒中的概念演变
Continuum (Minneap Minn). 2020 Apr;26(2):353-362. doi: 10.1212/CON.0000000000000832.
4
[Cryptogenic stroke management : where are we ?].[隐源性卒中的管理:我们目前处于什么阶段?]
Ann Cardiol Angeiol (Paris). 2021 Dec;70(6):373-379. doi: 10.1016/j.ancard.2021.10.006. Epub 2021 Nov 4.
8
Cryptogenic stroke.隐源性卒中
Eur J Neurol. 2015 Apr;22(4):618-23. doi: 10.1111/ene.12673. Epub 2015 Jan 18.
9
Cryptogenic Stroke: Research and Practice.隐源性卒中:研究与实践。
Circ Res. 2017 Feb 3;120(3):527-540. doi: 10.1161/CIRCRESAHA.116.308447.

引用本文的文献

本文引用的文献

7
Cancer and Embolic Stroke of Undetermined Source.无法确定来源的癌症和栓塞性脑卒中。
Stroke. 2021 Mar;52(3):1121-1130. doi: 10.1161/STROKEAHA.120.032002. Epub 2021 Jan 28.
8
What do we do about atrial high rate episodes?对于房性快速心律失常发作我们该如何应对?
Eur Heart J Suppl. 2020 Dec 22;22(Suppl O):O42-O52. doi: 10.1093/eurheartj/suaa179. eCollection 2020 Dec.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验